Treating tardive dyskinesia (TD) with INGREZZA: See the results

Actor portrayals

INGREZZA® (valbenazine) capsules is the only treatment proven to reduce TD that's always one capsule, once daily. And it's #1 prescribed‍.

7 out of 10 people

In a clinical study, 7 out of 10 people taking INGREZZA 80 mg saw reduction in uncontrollable body movements at 6 weeks.*

Results in 6 weeks

And in the same clinical study, many people taking INGREZZA began to see results in as little as 2 weeks.

48 weeks of continued reduction

In a long-term study, INGREZZA provided continued reduction in uncontrollable body movements through 48 weeks.

*Patients had at least a 1-point reduction on an uncontrollable movement severity scale at 6 weeks vs before treatment. This post-clinical study evaluation included 70 patients taking INGREZZA 80 mg, measuring uncontrollable movements before starting treatment and at 6 weeks of treatment.

INGREZZA was studied in a 6-week clinical trial. A total of 234 people participated in the study. Results were based on 79 people taking the recommended dose of 80 mg.

Actor portrayal

INGREZZA and your mental health

In a clinical study, psychiatric status remained stable overall in people taking INGREZZA for TD, including those who were also taking medicine for:

  • Depression
  • Schizophrenia/schizoaffective disorder
  • Bipolar disorder
  • Anxiety disorder

Learn more about the INGREZZA clinical study

This study measured the difference in people’s uncontrollable movements at 6 weeks, 48 weeks, and at certain times in between. Participants had moderate to severe TD and schizophrenia, schizoaffective disorder, or mood disorder.

Actor portrayals

How INGREZZA works

Some mental health medicines (antipsychotics) can cause abnormal dopamine signaling in the brain. This abnormal signaling can lead to uncontrollable body movements called tardive dyskinesia.

Current research suggests that INGREZZA helps by correcting this abnormal dopamine signaling; however, how INGREZZA works to treat TD is not fully understood.

  • Dopamine is a chemical in the brain that helps control movement
  • TD may be caused by too much dopamine signaling in the brain
  • INGREZZA is believed to reduce extra dopamine signaling

For questions about INGREZZA, call 1-84-INGREZZA (1-844-647-3992)

Did you know?
Since tardive dyskinesia (TD) is unlikely to get better on its own, it is important to take control and talk to your healthcare provider about treatment.

People taking INGREZZA for TD can stay on their current dose of most mental health medicines.

INGREZZA side effects

In a clinical study, the most common side effect of INGREZZA in people with tardive dyskinesia
was sleepiness.

INGREZZA may cause serious side effects, including:

  • Sleepiness
  • Heart rhythm problems
  • Abnormal movements, including shaking, body stiffness, trouble moving or walking, or keeping your balance

Other side effects include:

  • Changes in balance (balance problems, dizziness) or increased risk of falls
  • Headache
  • Feelings of restlessness
  • Dry mouth
  • Constipation
  • Blurred vision

These are not all of the possible side effects of INGREZZA.

If you experience side effects, call your healthcare provider for medical advice. To report side effects to the FDA, call 1-800-FDA-1088.

Looking for help talking to your healthcare provider about your TD movements?

You can use our discussion guide to have a more productive conversation with your healthcare provider about tardive dyskinesia (TD) and INGREZZA.

Complete the Discussion Guide

Ready to take the next step?
Find a specialist.

You’ve worked hard to improve your mental health. Don’t let uncontrollable movements hold you back.

Take an important step forward by connecting with a psychiatry or neurology healthcare provider who has experience diagnosing and treating TD.

Find a specialist now

You are now leaving

Neurocrine Biosciences, Inc. is not responsible for the content of linked third-party websites. Please be aware that the privacy policies and terms of use on these sites are different from Neurocrine Biosciences, Inc. policies.